1. Home
  2. CYTK vs DDS Comparison

CYTK vs DDS Comparison

Compare CYTK & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$684.16

Market Cap

9.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
DDS
Founded
1997
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
DDS
Price
$62.41
$684.16
Analyst Decision
Strong Buy
Sell
Analyst Count
16
3
Target Price
$82.38
$511.33
AVG Volume (30 Days)
2.2M
150.1K
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
4.58%
EPS Growth
N/A
N/A
EPS
N/A
36.93
Revenue
$87,211,000.00
$6,625,563,000.00
Revenue This Year
$346.43
$1.30
Revenue Next Year
$57.69
$0.57
P/E Ratio
N/A
$18.44
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$282.24
52 Week High
$70.98
$741.98

Technical Indicators

Market Signals
Indicator
CYTK
DDS
Relative Strength Index (RSI) 49.43 59.98
Support Level $62.05 $644.28
Resistance Level $66.59 $669.69
Average True Range (ATR) 2.97 24.97
MACD 0.09 4.64
Stochastic Oscillator 33.47 94.27

Price Performance

Historical Comparison
CYTK
DDS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

Share on Social Networks: